NCT01323569 - Abuse Potential of Sativex | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Evaluation of Abuse Potential of Sativex

Interventions

DRUG

Sativex

Sativex dose level 1: 10.8 mg THC/10 mg CBD (4 sprays) + 12 placebo sprays + 4 placebo capsules.

DRUG

Sativex

Sativex dose level 2: 21.6 mg THC/20 mg CBD (8 sprays) + 8 placebo sprays + 4 placebo capsules

DRUG

Sativex

Sativex dose level 3: 43.2 mg THC/40 mg CBD (16 sprays) + 4 placebo capsules

DRUG

Placebo

16 placebo sprays and 4 placebo capsules

DRUG

Marinol

Marinol dose level 1: 20 mg THC (2 marinol capsules) + 2 placebo capsules + 16 placebo sprays

DRUG

Marinol

Marinol dose level 2: 40 mg THC (4 marinol capsules) + 16 placebo sprays

Trial Locations (1)

DecisionLine Clinical Research Corporation, Toronto